Investors Heavily Search Starbucks Corporation (SBUX): Here is What You Need to Know

Starbucks (SBUX) has significantly underperformed the S&P 500 over the past month, returning only +0.3% against the index's +4.2%. Analysts have notably revised down current quarter and fiscal year EPS estimates, with the current quarter projected at $0.64, a -31.2% year-over-year decline, and the current fiscal year at $2.48, down -25.1%. This, coupled with a history of largely missing EPS estimates and a premium valuation (Zacks Value Style Score D), has resulted in a Zacks Rank #4 (Sell), indicating potential near-term underperformance for SBUX.

Analysis

Starbucks (SBUX) is exhibiting significant fundamental weakness, leading to marked stock underperformance with a +0.3% return over the past month compared to the S&P 500 composite's +4.2% gain. The primary driver of this negative outlook is a consistent downward revision of earnings estimates by sell-side analysts. For the current quarter, earnings are projected to decline 31.2% year-over-year to $0.64 per share, with the consensus estimate falling 2.3% in the last 30 days. This trend extends to the full fiscal year, where a 25.1% YoY earnings decrease is anticipated. Even the forecast for a 19.5% earnings recovery in the next fiscal year is being trimmed, with estimates revised down 2.1% recently. This sentiment is validated by the company's recent performance, where it missed EPS estimates by a substantial 16.33% and has failed to meet EPS consensus in three of the last four quarters. Compounding these issues are sluggish revenue growth forecasts of just +1.8% for the current quarter and a premium valuation, reflected by a Zacks Value Style Score of 'D'. The confluence of declining earnings, weak revenue growth, and rich valuation underpins the stock's Zacks Rank #4 (Sell), indicating a high probability of near-term underperformance.

Key Decisions for Investors

• Given the persistent negative earnings revisions and a Zacks Rank #4 (Sell), investors should exercise extreme caution, as the stock is positioned to underperform the broader market in the near term.
• The stock's premium valuation, indicated by a 'D' grade for value, appears unjustified in the face of a projected 25.1% decline in current fiscal year earnings, suggesting significant downside risk if fundamentals do not improve.
• Investors should closely monitor upcoming earnings reports for any stabilization in revenue growth and earnings outlook before considering a long position, as the forecast for a next-year rebound is already showing signs of weakness.
• Current holders might consider reducing exposure or employing hedging strategies to mitigate risks associated with deteriorating analyst sentiment and poor earnings momentum.